Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$583K Buy
6,951
+6,551
+1,638% +$540K 0.04% 253
2025
Q2
$31.7K Buy
+400
New +$31.8K ﹤0.01% 1160
2025
Q1
Sell
-9,902
Closed -$925K 1913
2024
Q4
$985K Sell
9,902
-118,608
-92% -$12.2M 0.04% 475
2024
Q3
$14.6M Buy
128,510
+77,968
+154% +$9.26M 0.49% 42
2024
Q2
$6.26M Sell
50,542
-73,897
-59% -$9.52M 0.22% 120
2024
Q1
$16.4M Buy
+124,439
New +$15.3M 0.52% 32

Other funds holding MRK

Point72 (DIFC)'s MRK Position: Q3 2025 in Review

Point72 (DIFC) increased its Merck (MRK) stake by 1,638% in Q3 2025, buying an estimated $540K and bringing the position to 6,951 shares worth $583K. The position accounts for 0.04% of the portfolio, ranked #253.

Point72 (DIFC) first reported a position in MRK in Q1 2024 and has held it in 6 quarters since. The position peaked at $16.4M in Q1 2024. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Point72 (DIFC) held 6,951 shares of Merck worth $583K as of Q3 2025.
  • Point72 (DIFC) bought 6,551 Merck shares in Q3 2025, an estimated $540K.
  • Merck made up 0.04% of Point72 (DIFC)'s portfolio in Q3 2025, its #253 holding.
  • Point72 (DIFC) first reported a position in Merck in Q1 2024 and has held it in 6 quarters since.
  • Point72 (DIFC)'s Merck position peaked at $16.4M in Q1 2024.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.